dsip peptide nasal 10ML Research Spray DSIP Peptide Dosage Chart &
Description
Semaglutide Component Properties Complete Specifications: Classification: GLP-1 receptor agonist Molecular Weight: 4,113 Da Molecular Formula: CHNO Structural Basis: Modified human GLP-1(7-37) with Aib8 and C18 fatty acid at K26 Key Modifications: Aminoisobutyric acid (Aib) at position 8, C18 fatty diacid at K26, linker modifications Primary Target: GLP-1 receptors (class B GPCR) Mechanism: GLP-1 receptor agonism with 94% albumin binding Plasma Half-Life: ~165 hours (~7 days), enabling once-weekly research administration CAS Number: 910463-68-2 Appearance: White to off-white lyophilized powder The semaglutide component provides long-acting GLP-1 receptor activation research capabilities
Degradation during GI transit is a real concern given its linear unmodified structure
Deposit Schemes We have two deposit schemes for you, one is Deposit Pension Scheme and another one is the Fixed Deposit Receipt
Hathaway JT, Shah MP, Hathaway DB, et al
& OMalley, P
